IAM Advisory LLC Takes $1.46 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

IAM Advisory LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 15,334 shares of the exchange traded fund’s stock, valued at approximately $1,455,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in SPDR S&P Biotech ETF by 35.9% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock worth $214,832,000 after purchasing an additional 635,000 shares in the last quarter. Phoenix Holdings Ltd. lifted its stake in SPDR S&P Biotech ETF by 0.8% in the 3rd quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock worth $157,092,000 after purchasing an additional 17,221 shares in the last quarter. MBB Public Markets I LLC boosted its stake in SPDR S&P Biotech ETF by 67.0% during the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after buying an additional 206,337 shares during the period. Finally, Employees Retirement System of Texas purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $27,456,000.

SPDR S&P Biotech ETF Stock Down 1.0 %

Shares of XBI stock traded down $0.91 during trading on Wednesday, hitting $92.17. The company had a trading volume of 7,102,057 shares, compared to its average volume of 10,785,629. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The stock has a market capitalization of $7.03 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s 50-day moving average is $89.57 and its two-hundred day moving average is $90.61.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.